Calamos Advisors LLC Pfizer Inc Transaction History

Calamos Advisors LLC

$14.5 Billion
Q1 2024

A detailed history of Calamos Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Calamos Advisors LLC holds 1,348,334 shares of PFE stock, worth $37.7 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

1,348,334

Previous 1,373,276 1.82%

Holding current value

$37.7 Million

Previous $39.5 Million 5.36%

% of portfolio

0.26%

Previous 0.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $645,748 - $741,525	-24,942 Reduced 1.82%	1,348,334 $37.4 Million
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $296,680 - $385,354	-11,354 Reduced 0.82%	1,373,276 $39.5 Million
Q3 2023 Oct 25, 2023	BUY	$32.09 - $37.51 $41,331 - $48,312	1,288 Added 0.09%	1,384,630 $45.9 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $23,911 - $27,664	662 Added 0.05%	1,383,342 $50.7 Million
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $5.22 Million - $6.79 Million	-132,472 Reduced 8.74%	1,382,680 $56.4 Million

Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $8.8 Million - $11.5 Million	-210,709 Reduced 12.21%	1,515,152 $0
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $6.02 Million - $7.35 Million	-137,558 Reduced 7.38%	1,725,861 $75.5 Million
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $6.08 Million - $7.21 Million	130,641 Added 7.54%	1,863,419 $97.7 Million
Q1 2022 May 03, 2022	BUY	$45.75 - $56.69 $8.36 Million - $10.4 Million	182,747 Added 11.79%	1,732,778 $89.7 Million
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $709,009 - $1.05 Million	-17,159 Reduced 1.09%	1,550,031 $91.5 Million
Q3 2021 Oct 26, 2021	BUY	$39.25 - $50.42 $6.96 Million - $8.94 Million	177,387 Added 12.76%	1,567,190 $67.4 Million
Q2 2021 Jul 22, 2021	BUY	$35.91 - $40.68 $8.97 Million - $10.2 Million	249,928 Added 21.93%	1,389,803 $54.4 Million
Q1 2021 Apr 12, 2021	BUY	$33.49 - $37.77 $878,878 - $991,198	26,243 Added 2.36%	1,139,875 $41.3 Million
Q4 2020 Jan 27, 2021	SELL	$33.47 - $42.56 $1.21 Million - $1.54 Million	-36,154 Reduced 3.14%	1,113,632 $41 Million
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $8.2 Million - $9.62 Million	-258,383 Reduced 18.35%	1,149,786 $42.2 Million
Q2 2020 Jul 27, 2020	SELL	$30.12 - $36.54 $1.82 Million - $2.21 Million	-60,408 Reduced 4.11%	1,408,169 $46 Million
Q1 2020 Apr 28, 2020	SELL	$27.03 - $38.62 $52.2 Million - $74.5 Million	-1,929,737 Reduced 56.79%	1,468,577 $47.9 Million
Q4 2019 Jan 15, 2020	BUY	$32.92 - $37.36 $4.69 Million - $5.32 Million	142,490 Added 4.38%	3,398,314 $133 Million
Q3 2019 Oct 21, 2019	SELL	$32.49 - $42.13 $3.65 Million - $4.73 Million	-112,210 Reduced 3.33%	3,255,824 $117 Million
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $17.8 Million - $20 Million	482,579 Added 16.72%	3,368,034 $146 Million
Q1 2019 Apr 12, 2019	BUY	$37.5 - $41.2 $25.7 Million - $28.2 Million	684,490 Added 31.1%	2,885,455 $123 Million
Q4 2018 Jan 24, 2019	BUY	$38.47 - $43.86 $5.21 Million - $5.94 Million	135,528 Added 6.56%	2,200,965 $96.1 Million
Q3 2018 Oct 22, 2018	SELL	$34.47 - $41.81 $1.75 Million - $2.12 Million	-50,686 Reduced 2.4%	2,065,437 $91 Million
Q2 2018 Jul 17, 2018	BUY	$32.98 - $35.16 $3.37 Million - $3.59 Million	102,245 Added 5.08%	2,116,123 $76.8 Million
Q1 2018 Apr 13, 2018	BUY	$31.91 - $37.02 $944,504 - $1.1 Million	29,599 Added 1.49%	2,013,878 $71.5 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $1.51 Million - $1.61 Million	-45,521 Reduced 2.24%	1,984,279 $71.9 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $861,800 - $949,370	27,800 Added 1.39%	2,029,800 $72.5 Million
Q2 2017 Aug 09, 2017	BUY	N/A	2,002,000	2,002,000 $67.2 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Pfizer Inc Transaction History